Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Patients who are overweight and have weight-related health concerns may also be considered for treatment depending on provider assessment
Important Safety Considerations Semaglutide is not recommended for those with (Kommu & Whitfield, 2024) : Personal/family history of medullary thyroid carcinoma MEN2 Previous pancreatitis It can also increase the risk of hypoglycemia when used with insulin or sulfonylureas(Kommu & Whitfield, 2024)
Olezarsen for hypertriglyceridemia in patients at high cardiovascular risk
Semaglutide resists rapid breakdown
Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more affordable
Frequently Asked Questions How do weight loss injections work
